Literature DB >> 11114143

Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study.

L Pagano, L Mele, I Casorelli, L Fianchi, A Di Febo , G Leone.   

Abstract

Acute myeloid leukemia in elderly patients is a well-studied disease, while only a few studies on acute lymphoid leukemia (ALL) in elderly patients have been reported and their results are not encouraging. The aims of the present study were to review the characteristics of acute lymphoblastic leukemia developing in patients aged over 65 years old during a twelve-year period at our Institution and to analyze the clinical and laboratory characteristics.

Entities:  

Mesh：

Year:  2000        PMID： 11114143

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  8 in total

Review 1.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.

Authors:  Mathilde Hunault-Berger; Thibaut Leguay; Xavier Thomas; Ollivier Legrand; Françoise Huguet; Caroline Bonmati; Martine Escoffre-Barbe; Laurence Legros; Pascal Turlure; Patrice Chevallier; Fabrice Larosa; Frederic Garban; Oumedaly Reman; Philippe Rousselot; Nathalie Dhédin; André Delannoy; Marina Lafage-Pochitaloff; Marie Christine Béné; Norbert Ifrah; Hervé Dombret
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

Review 3.  Optimal pharmacotherapeutic management of acute lymphoblastic leukaemia in the elderly.

Authors:  Philippe Rousselot; André Delannoy
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

Review 4.  Treatment of older patients with acute lymphoblastic leukemia.

Authors:  Nicola Gökbuget
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 5.  Treatment of Older Patients with Acute Lymphoblastic Leukaemia.

Authors:  Nicola Gökbuget
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

Review 6.  Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Matt Stevenson; Abdullah Pandor; Jean Hamilton; John Stevens; Clare Rowntree; Marrissa Martyn-St James; Andrew Rawdin; Ruth Wong
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

Review 7.  Acute lymphoblastic leukaemia in elderly patients: biological characteristics and therapeutic approaches.

Authors:  Tadeusz Robak
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports.

Authors:  Jie Lin; Hongli Zhu; Suxia Li; Hui Fan; Xuechun Lu; Cheng Chang; Bo Guo; Bing Zhai
Journal:  Oncol Lett       Date:  2013-01-18       Impact factor: 2.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.